A Nature Mental Health paper co-authored by Stanford’s Shebani Sethi reviews evidence linking metabolic dysfunction to serious psychiatric disorders.

Emerging diabetes therapies are transforming MASLD treatment by addressing both metabolic dysfunction and liver disease, with new approvals and a growing pipeline signaling a shift in care. A rapidly ...

A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...

That program, which focused on improving participants' metabolic health, offers a clear glimpse of what's possible when we ...

Shebani Sethi is at the vanguard of metabolic psychiatry, a field that investigates the link between diet and serious mental ...

Atrial fibrillation (AFib) is the most common cardiac arrhythmia worldwide and a major contributor to heart failure (HF), ...

Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, ...

Lifestyle changes, medications, and emerging therapies can help treat or reverse metabolic dysfunction-associated steatotic liver disease (MASLD) for some people. Metabolic dysfunction-associated ...

Cardiometabolic research has increasingly recognized the centrality of metabolic dysregulation and dietary imbalances in the development and progression of ...

A 2026 multicentre study, named DiaFib-Liver Study, found a connection in an often-overlooked complication of Type 2 Diabetes ...

Metabolic syndrome (MetS) is a multifaceted disorder characterized by a constellation of metabolic abnormalities, including central obesity, dyslipidemia, ...